Cubist Systematic Strategies, LLC Axsome Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $4,163 - $5,858	60 New	60 $4,000
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $2.66 Million - $5.31 Million	-66,634 Reduced 87.87%	9,199 $709,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $1.53 Million - $2.97 Million	42,465 Added 127.26%	75,833 $3.38 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $323,969 - $696,668	14,902 Added 80.7%	33,368 $1.28 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $230,482 - $402,517	-9,725 Reduced 34.5%	18,466 $764,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $586,155 - $827,872	-19,093 Reduced 40.38%	28,191 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $941,424 - $3.23 Million	47,284 New	47,284 $1.56 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $851,748 - $1.24 Million	-16,823 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $805,830 - $1.17 Million	14,413 Added 598.05%	16,823 $953,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $20,290 - $26,475	306 Added 14.54%	2,410 $196,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $221,489 - $278,207	-3,241 Reduced 60.64%	2,104 $150,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $111,559 - $220,769	2,237 Added 71.98%	5,345 $440,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $683,013 - $1.68 Million	-16,578 Reduced 84.21%	3,108 $183,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $254,994 - $1.62 Million	15,260 Added 344.78%	19,686 $2.04 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $224,319 - $323,180	-11,083 Reduced 71.46%	4,426 $90,000
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $208,751 - $399,356	15,509 New	15,509 $399,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account